NPR3 and Ventriculomegaly: Specifically, the mice lacking NPR-C that were treated with Ang II showed a much more severe decline in cardiac function and decompensation into overt HFrEF as indicated by ventricular dilatation and reductions in EF and FS (Mackasey et al., 2018).